266 related articles for article (PubMed ID: 22240785)
1. Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma.
Nordenstedt H; Mattsson F; El-Serag H; Lagergren J
Br J Cancer; 2012 Feb; 106(5):1011-5. PubMed ID: 22240785
[TBL] [Abstract][Full Text] [Related]
2. Risk of extrahepatic bileduct cancer after cholecystectomy.
Ekbom A; Hsieh CC; Yuen J; Trichopoulos D; McLaughlin JK; Lan SJ; Adami HO
Lancet; 1993 Nov; 342(8882):1262-5. PubMed ID: 7901583
[TBL] [Abstract][Full Text] [Related]
3. Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.
Jepsen P; Vilstrup H; Tarone RE; Friis S; Sørensen HT
J Natl Cancer Inst; 2007 Jun; 99(11):895-7. PubMed ID: 17551150
[TBL] [Abstract][Full Text] [Related]
4. Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study.
Kamal H; Sadr-Azodi O; Engstrand L; Brusselaers N
Hepatology; 2021 Oct; 74(4):2021-2031. PubMed ID: 34018229
[TBL] [Abstract][Full Text] [Related]
5. Gallstones and the Risk of Gallbladder Cancer Mortality: A Cohort Study.
Ryu S; Chang Y; Yun KE; Jung HS; Shin JH; Shin H
Am J Gastroenterol; 2016 Oct; 111(10):1476-1487. PubMed ID: 27575712
[TBL] [Abstract][Full Text] [Related]
6. Cholecystectomy reduces the risk of cholangiocarcinoma in patients with complicated gallstones, but has negligible effect on hepatocellular carcinoma.
Ahn HS; Kim HJ; Kang TU; Park SM
J Gastroenterol Hepatol; 2022 Apr; 37(4):669-677. PubMed ID: 34907591
[TBL] [Abstract][Full Text] [Related]
7. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States.
Welzel TM; McGlynn KA; Hsing AW; O'Brien TR; Pfeiffer RM
J Natl Cancer Inst; 2006 Jun; 98(12):873-5. PubMed ID: 16788161
[TBL] [Abstract][Full Text] [Related]
8. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas.
Chow WH; Johansen C; Gridley G; Mellemkjaer L; Olsen JH; Fraumeni JF
Br J Cancer; 1999 Feb; 79(3-4):640-4. PubMed ID: 10027343
[TBL] [Abstract][Full Text] [Related]
9. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
[TBL] [Abstract][Full Text] [Related]
10. Association of Endoscopic Sphincterotomy or Papillary Balloon Dilatation and Biliary Cancer: A Population-Based Cohort Study.
Peng YC; Lin CL; Hsu WY; Chow WK; Lee SW; Yeh HZ; Chang CS; Kao CH
Medicine (Baltimore); 2015 Jun; 94(23):e926. PubMed ID: 26061315
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
[TBL] [Abstract][Full Text] [Related]
12. Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia.
Shin HR; Oh JK; Masuyer E; Curado MP; Bouvard V; Fang Y; Wiangnon S; Sripa B; Hong ST
Asian Pac J Cancer Prev; 2010; 11(5):1159-66. PubMed ID: 21198257
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.
Esnaola NF; Meyer JE; Karachristos A; Maranki JL; Camp ER; Denlinger CS
Cancer; 2016 May; 122(9):1349-69. PubMed ID: 26799932
[TBL] [Abstract][Full Text] [Related]
14. Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: Demographics, pathology and survival.
Koea J; Phillips A; Lawes C; Rodgers M; Windsor J; McCall J
ANZ J Surg; 2002 Dec; 72(12):857-61. PubMed ID: 12485219
[TBL] [Abstract][Full Text] [Related]
15. [Case-control study of risk factors in cholangiocarcinoma].
Tao LY; He XD; Cai L; Liu W; Ji WJ; Zhao L; Zhang SM
Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):759-63. PubMed ID: 20021829
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM
Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
[TBL] [Abstract][Full Text] [Related]
17. S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.
Tsai JH; Huang WC; Kuo KT; Yuan RH; Chen YL; Jeng YM
Histopathology; 2012 Dec; 61(6):1106-16. PubMed ID: 22882148
[TBL] [Abstract][Full Text] [Related]
18. Current epidemiology of cholangiocarcinoma in Western countries.
Vithayathil M; Khan SA
J Hepatol; 2022 Dec; 77(6):1690-1698. PubMed ID: 35977611
[TBL] [Abstract][Full Text] [Related]
19. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
20. Cholangiocarcinoma.
Patel T
Nat Clin Pract Gastroenterol Hepatol; 2006 Jan; 3(1):33-42. PubMed ID: 16397610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
